Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow
2007-01-01 Danese, S
Ulcerative Colitis
2011-01-01 Danese, S; Fiocchi, C
Integrated models of care in managing inflammatory bowel disease: a discussion
2012-01-01 Mikocka-Walus, Aa; Andrews, Jm; Bernstein, Cn; Graff, La; Walker, Jr; Spinelli, A; Danese, S; Van Der Woude, Cj; Goodhand, J; Rampton, D; Moser, G.
Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis
2020-01-01 Pellino, G; Keller, D S; Sampietro, G M; Carvello, M; Celentano, V; Coco, C; Colombo, F; Geccherle, A; Luglio, G; Rottoli, M; Scarpa, M; Sciaudone, G; Sica, G; Sofo, L; Zinicola, R; Leone, S; Danese, S; Spinelli, A; Delaini, G; Selvaggi, F
Mesenchymal stromal cells in inflammatory bowel disease: conspirators within the 'colitogenic niche'?
2013-01-01 Danese, S; Rutella, S; Vetrano, S
IBD Mucosal healing-EXTENDing our knowledge in Crohn's disease
2012-01-01 Danese, S; Peyrin-Biroulet, L
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
2019-01-01 Sands, Be; Peyrin-Biroulet, L; Loftus, Ev; Danese, S; Colombel, Jf; Toruner, M; Jonaitis, L; Abhyankar, B; Chen, J; Rogers, R; Lirio, Ra; Bornstein, Jd; Schreiber, S
Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2
2018-01-01 Feagan, Bg; Schwartz, D; Danese, S; Rubin, Dt; Lissoos, Tw; Xu, J; Lasch, K
High prevalence of infection by H. pylori cytotoxic type I strains in recurrent spontaneous abortion
1999-01-01 Torre, Es; Gasbarrini, A; Trivellini, C; De Carolis, S; Camilli, Fm; Ojetti, V; Candelli, M; Franceschi, F; Armuzzi, A; Danese, S; Pola, P; Caruso, A; Gasbarrini, G
Correlation between delta(CO2)-C-13 excretion and prevalence of dyspeptic symptoms in subjects evaluated for H. pylori infection by C-13-urea breath test
1999-01-01 Franceschi, F; Armuzzi, A; Maniccia, E; Ojetti, V; Torre, Es; Candelli, M; Gabrielli, M; Danese, S; Canducci, F; Cremonini, F; Carloni, E; Anti, M; Gasbarrini, G; Gasbarrini, A
Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition
2018-01-01 Goncalves, J; Santos, M; Acurcio, R; Iria, I; Gouveia, L; Brito, Pm; Cunha-Santos, Ac; Barbas, A; Galvao, J; Barbosa, I; da Silva, Fa; Alcobia, A; Cavaco, M; Cardoso, M; Alves, Jd; Carey, Jj; Dorner, T; Fonseca, Je; Palmela, C; Torres, J; Vieira, Cl; Trabuco, D; Fiorino, G; Strik, A; Yavzori, M; Rosa, I; Correia, L; Magro, F; D'Haens, G; Ben-Horin, S; Lakatos, Pl; Danese, S
Serum bile acids profiling in IBD patients treated with anti-TNFs
2019-01-01 Roda, G; Porru, E; Katsanos, K; Skamnelos, A; Kyriakidi, K; Christodoulou, Dk; Caliceti, C; Fiorino, G; Danese, S; Roda, A
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases
2020-01-01 Kim, H; Alten, R; Avedano, L; Dignass, A; Gomollon, F; Greveson, K; Halfvarson, J; Irving, Pm; Jahnsen, J; Lakatos, Pl; Lee, J; Makri, S; Parker, B; Peyrin-Biroulet, L; Schreiber, S; Simoens, S; Westhovens, R; Danese, S; Jeong, Jh
Immune regulation by microvascular endothelial cells: Directing innate and adaptive immunity, coagulation, and inflammation
2007-01-01 Danese, S; Dejana, E; Fiocchi, C
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
2011-01-01 Gadaleta, Rm; Van Erpecum, Kj; Oldenburg, B; Willemsen, Ecl; Renooij, W; Murzilli, S; Klomp, Lwj; Siersema, Pd; Schipper, Mei; Danese, S; Penna, G; Laverny, G; Adorini, L; Moschetta, A; Van Mil, Swc
Next generation of small molecules in inflammatory bowel disease
2017-01-01 Olivera, P; Danese, S; Peyrin-Biroulet, L
Cost-effectiveness of biological treatment sequences for fistulising Crohn's disease across Europe
2018-01-01 Baji, P; Gulacsi, L; Brodszky, V; Vegh, Z; Danese, S; Irving, Pm; Peyrin-Biroulet, L; Schreiber, S; Rencz, F; Lakatos, Pl; Pentek, M
Inflammatory bowel diseases and psychological issues: A new approach for a systematic analysis of the academic debate
2014-01-01 Barello, S; Leone, D; Danese, S; Vegni, E
Can IL-23 be a good target for ulcerative colitis?
2018-01-01 Allocca, M; Furfaro, F; Fiorino, G; Gilardi, D; D'Alessio, S; Danese, S
Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer
2004-01-01 Danese, S; Papa, A; Gasbarrini, A; Ricci, R; Maggiano, N
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow | 1-gen-2007 | Danese, S | |
| Ulcerative Colitis | 1-gen-2011 | Danese, S; Fiocchi, C | |
| Integrated models of care in managing inflammatory bowel disease: a discussion | 1-gen-2012 | Mikocka-Walus, Aa; Andrews, Jm; Bernstein, Cn; Graff, La; Walker, Jr; Spinelli, A; Danese, S; Van Der Woude, Cj; Goodhand, J; Rampton, D; Moser, G. | |
| Inflammatory bowel disease position statement of the Italian Society of Colorectal Surgery (SICCR): ulcerative colitis | 1-gen-2020 | Pellino, G; Keller, D S; Sampietro, G M; Carvello, M; Celentano, V; Coco, C; Colombo, F; Geccherle, A; Luglio, G; Rottoli, M; Scarpa, M; Sciaudone, G; Sica, G; Sofo, L; Zinicola, R; Leone, S; Danese, S; Spinelli, A; Delaini, G; Selvaggi, F | |
| Mesenchymal stromal cells in inflammatory bowel disease: conspirators within the 'colitogenic niche'? | 1-gen-2013 | Danese, S; Rutella, S; Vetrano, S | |
| IBD Mucosal healing-EXTENDing our knowledge in Crohn's disease | 1-gen-2012 | Danese, S; Peyrin-Biroulet, L | |
| Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis | 1-gen-2019 | Sands, Be; Peyrin-Biroulet, L; Loftus, Ev; Danese, S; Colombel, Jf; Toruner, M; Jonaitis, L; Abhyankar, B; Chen, J; Rogers, R; Lirio, Ra; Bornstein, Jd; Schreiber, S | |
| Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2 | 1-gen-2018 | Feagan, Bg; Schwartz, D; Danese, S; Rubin, Dt; Lissoos, Tw; Xu, J; Lasch, K | |
| High prevalence of infection by H. pylori cytotoxic type I strains in recurrent spontaneous abortion | 1-gen-1999 | Torre, Es; Gasbarrini, A; Trivellini, C; De Carolis, S; Camilli, Fm; Ojetti, V; Candelli, M; Franceschi, F; Armuzzi, A; Danese, S; Pola, P; Caruso, A; Gasbarrini, G | |
| Correlation between delta(CO2)-C-13 excretion and prevalence of dyspeptic symptoms in subjects evaluated for H. pylori infection by C-13-urea breath test | 1-gen-1999 | Franceschi, F; Armuzzi, A; Maniccia, E; Ojetti, V; Torre, Es; Candelli, M; Gabrielli, M; Danese, S; Canducci, F; Cremonini, F; Carloni, E; Anti, M; Gasbarrini, G; Gasbarrini, A | |
| Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition | 1-gen-2018 | Goncalves, J; Santos, M; Acurcio, R; Iria, I; Gouveia, L; Brito, Pm; Cunha-Santos, Ac; Barbas, A; Galvao, J; Barbosa, I; da Silva, Fa; Alcobia, A; Cavaco, M; Cardoso, M; Alves, Jd; Carey, Jj; Dorner, T; Fonseca, Je; Palmela, C; Torres, J; Vieira, Cl; Trabuco, D; Fiorino, G; Strik, A; Yavzori, M; Rosa, I; Correia, L; Magro, F; D'Haens, G; Ben-Horin, S; Lakatos, Pl; Danese, S | |
| Serum bile acids profiling in IBD patients treated with anti-TNFs | 1-gen-2019 | Roda, G; Porru, E; Katsanos, K; Skamnelos, A; Kyriakidi, K; Christodoulou, Dk; Caliceti, C; Fiorino, G; Danese, S; Roda, A | |
| The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases | 1-gen-2020 | Kim, H; Alten, R; Avedano, L; Dignass, A; Gomollon, F; Greveson, K; Halfvarson, J; Irving, Pm; Jahnsen, J; Lakatos, Pl; Lee, J; Makri, S; Parker, B; Peyrin-Biroulet, L; Schreiber, S; Simoens, S; Westhovens, R; Danese, S; Jeong, Jh | |
| Immune regulation by microvascular endothelial cells: Directing innate and adaptive immunity, coagulation, and inflammation | 1-gen-2007 | Danese, S; Dejana, E; Fiocchi, C | |
| Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease | 1-gen-2011 | Gadaleta, Rm; Van Erpecum, Kj; Oldenburg, B; Willemsen, Ecl; Renooij, W; Murzilli, S; Klomp, Lwj; Siersema, Pd; Schipper, Mei; Danese, S; Penna, G; Laverny, G; Adorini, L; Moschetta, A; Van Mil, Swc | |
| Next generation of small molecules in inflammatory bowel disease | 1-gen-2017 | Olivera, P; Danese, S; Peyrin-Biroulet, L | |
| Cost-effectiveness of biological treatment sequences for fistulising Crohn's disease across Europe | 1-gen-2018 | Baji, P; Gulacsi, L; Brodszky, V; Vegh, Z; Danese, S; Irving, Pm; Peyrin-Biroulet, L; Schreiber, S; Rencz, F; Lakatos, Pl; Pentek, M | |
| Inflammatory bowel diseases and psychological issues: A new approach for a systematic analysis of the academic debate | 1-gen-2014 | Barello, S; Leone, D; Danese, S; Vegni, E | |
| Can IL-23 be a good target for ulcerative colitis? | 1-gen-2018 | Allocca, M; Furfaro, F; Fiorino, G; Gilardi, D; D'Alessio, S; Danese, S | |
| Helicobacter pylori eradication down-regulates matrix metalloproteinase-9 expression in chronic gastritis and gastric ulcer | 1-gen-2004 | Danese, S; Papa, A; Gasbarrini, A; Ricci, R; Maggiano, N |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista39385
Data di pubblicazione
- In corso di stampa9
- 2020 - 202711472
- 2010 - 201915948
- 2000 - 20097460
- 1990 - 19993485
- 1980 - 1989933
- 1970 - 197977
- 1959 - 19591
Editore
- Elsevier Inc.802
- Elsevier B.V.767
- John Wiley and Sons Inc524
- Springer Science and Business Med...516
- Oxford University Press483
- Lippincott Williams and Wilkins420
- Springer360
- MDPI347
- Elsevier Ltd330
- Springer Nature281
Rivista
- EUROPEAN UROLOGY529
- BLOOD372
- PLOS ONE312
- JOURNAL OF NEUROLOGY283
- EUROPEAN JOURNAL OF HEART FAILURE280
- NEUROLOGY268
- DIGESTIVE AND LIVER DISEASE245
- EUROPEAN HEART JOURNAL224
- MULTIPLE SCLEROSIS216
- SCIENTIFIC REPORTS212
Keyword
- Humans3553
- Male2080
- Female1864
- Middle Aged1472
- Aged1290
- Adult1100
- COVID-19629
- Retrospective Studies628
- Treatment Outcome603
- Prognosis481
Lingua
- eng28792
- ita1958
- fre64
- und55
- spa34
- ger25
- por12
- enm6
- rus6
- grc3
Accesso al fulltext
- no fulltext33605
- open3381
- reserved2292
- partially open99
- embargoed7
- mixed1